Skip to main content
Treatments

Local estrogen

Vaginal estrogen

A tiny dose of estrogen used right where it's needed. It's one of the most effective, lowest-bother treatments in midlife care, and one of the least talked about.

It's a separate question from systemic hormone therapy. It doesn't help hot flashes, but for the vagina, vulva and bladder it often helps a lot. General information to bring to your doctor or specialist, not a plan for you.

What it can help

Dryness, burning and painful sex

Lower estrogen thins the vaginal and vulval tissue. Local estrogen helps restore thickness, moisture and stretch. In trials it works better than placebo, and creams, tablets and rings work about equally well.

Source: Cochrane review, Lethaby 2016; The Menopause Society GSM 2020

Urgency, frequency and leaks

The bladder and urethra respond to estrogen too. Vaginal estrogen can ease urgency and frequency, and is often used alongside pelvic floor physiotherapy, bladder retraining or a pessary.

Source: The Menopause Society GSM 2020; NICE NG23

Repeat urinary tract infections

For people after menopause who get repeat UTIs, North American urology guidelines recommend vaginal estrogen to lower the chance of the next one.

Source: AUA/CUA/SUFU recurrent UTI guideline 2019

Prolapse and pessaries

Healthier tissue makes a pessary more comfortable and less likely to rub. It's often offered together with one.

Source: The Menopause Society GSM 2020

Using it

Cream, tablet, ring or insert

Cream or a small tablet is used nightly for about two weeks, then usually twice a week. A ring stays in for three months. Pick what fits your life. Most products use estradiol or estriol. Premarin vaginal cream uses conjugated estrogens, made from pregnant mares' urine. It works too. It just isn't body-identical.

Source: NICE NG23; Cochrane review, Lethaby 2016

Names you might hear

Tablets or inserts: Vagifem, Yuvafem, Imvexxy. Creams: Estrace, Premarin. Ring: Estring. Which ones you can get, and what they're called, depends on your country, so your pharmacist is the best guide. Your doctor or specialist sets the schedule.

Source: Product names, see the HRT doses and brands page

Where to put cream

Ask whether to use some on the vaginal opening (the vestibule) and around the urethra, not only inside. Cream on the vestibule eased painful sex in a small trial, and a fingertip around the urethra prevented repeat UTIs about as well as the applicator in a 2026 trial.

Source: Goetsch et al., Menopause 2023; TAPER trial, Obstetrics & Gynecology 2026

When you might notice a difference

Some people feel less dry or sore within the first few weeks, often during the nightly starting phase. Painful sex and bladder symptoms can take longer. Give it about three months, including time on the twice-weekly dose, before deciding it isn't working. If nothing has changed by then, go back to your doctor or specialist: the dose, the form or the cause may need another look.

Source: NICE NG23; The Menopause Society GSM 2020

How long you can use it

For as long as it helps. Symptoms usually come back when it stops, and there's no set time limit.

Source: NICE NG23; The Menopause Society GSM 2020

Usually no progesterone needed

The dose is so low that people with a uterus don't usually need progestogen alongside it. Any bleeding after menopause still needs checking.

Source: The Menopause Society GSM 2020

Alongside systemic HRT

You can use it on top of a patch, gel or pill if vaginal or bladder symptoms are still there.

Source: NICE NG23

Little is absorbed

In a large Women's Health Initiative cohort, vaginal estrogen wasn't linked to higher rates of heart disease, stroke, clots or breast cancer.

Source: Crandall et al., Menopause 2018

Also worth knowing

Vaginal DHEA (prasterone)

Sold as Intrarosa, it's a nightly insert. It isn't estrogen itself: the vaginal tissue turns it into small amounts of estrogen and testosterone locally. In trials it eased painful sex and dryness. It's an option when estrogen isn't the right fit.

Source: Labrie et al., Menopause 2016; The Menopause Society GSM 2020

While breastfeeding

Breastfeeding keeps estrogen low, so the same dryness, pain and bladder symptoms can show up after a birth. Researchers have proposed the name genitourinary syndrome of lactation (GSL). There are no treatment guidelines yet, so raise it with whoever does your postpartum care.

Source: Perelmuter et al., Sexual Medicine Reviews 2024

Arousal and orgasm

Lower arousal and weaker or harder-to-reach orgasms are part of the official definition of GSM. Mention them along with dryness and bladder symptoms, so the whole picture gets treated.

Source: Portman and Gass, Menopause 2014

If it stings, burns or itches more

Thin, sore tissue can sting at first with almost anything, and creams contain other ingredients besides the estrogen. If it doesn't settle within a week or two, or gets worse, tell your doctor or specialist. A tablet, insert or ring delivers the same kind of medicine in a different form. In one trial comparing a vaginal tablet with a cream, both eased symptoms equally, and fewer people stopped the tablet (10% compared with 32%).

Source: Rioux et al., Menopause 2000

Itching that won't settle

Ongoing itch isn't always dryness. Thrush, and skin conditions such as lichen sclerosus, are common in midlife and need different treatment. If itching keeps going, or the skin looks white, cracked or changed, ask to be examined.

Source: NHS: lichen sclerosus

What's safe to use while you wait

Oils and petroleum jelly weaken latex condoms within minutes, so use a water-based or silicone lubricant with condoms. In one US study, people who used petroleum jelly inside the vagina were about twice as likely to have bacterial vaginosis, and oil use was linked with more yeast. A vaginal moisturizer for everyday dryness (hyaluronic acid or polycarbophil based, from the pharmacy, used 2 to 3 times a week) and a lubricant for sex are the better-studied choices.

Source: Voeller et al., Contraception 1989; Brown et al., Obstetrics & Gynecology 2013; The Menopause Society GSM 2020

After breast cancer

Guidance says vaginal estrogen can be considered for many people after breast cancer when other options haven't helped enough, decided together with the oncology team. For people taking an aromatase inhibitor, one large Danish study found a small rise in recurrence risk, so that conversation matters more.

Source: ACOG Committee Opinion 659, 2016; Cold et al., JNCI 2022

Questions to bring

  • Could vaginal estrogen help my dryness, bladder or UTI symptoms?
  • Which would suit me best: cream, tablet, ring or insert?
  • Can I use it alongside my HRT, or instead of it?
  • This one stings or makes the itch worse. Could I try a different form?
  • It's been about three months and not much has changed. What should we look at next?
  • I've had breast cancer. Is it an option for me, and can we check with my oncology team?

References & further reading

Sources

The guidelines and studies behind this page.

Guidelines and studies

The 2020 genitourinary syndrome of menopause position statement

The Menopause Society

Effectiveness, long-term use, no routine progestogen, use with pessaries.

Visit

NG23: Menopause, identification and management

NICE (UK)

Use alongside HRT, no time limit, timing to judge effect.

Visit

Local oestrogen for vaginal atrophy in postmenopausal women

Lethaby et al., Cochrane 2016

Creams, tablets and rings work about equally well.

Visit

Recurrent uncomplicated urinary tract infections in women

AUA/CUA/SUFU guideline, 2019

Recommends vaginal estrogen after menopause to reduce repeat UTIs.

Visit

Postmenopausal vaginal estrogen use and chronic disease risk

Crandall et al., Menopause 2018 (WHI Observational Study)

No higher rates of heart disease, stroke, clots or breast cancer.

Visit

The use of vaginal estrogen in women with a history of estrogen-dependent breast cancer

ACOG Committee Opinion 659, 2016

Can be considered with the oncology team when other options fall short.

Visit

Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy

Portman and Gass, Menopause 2014 (ISSWSH and NAMS)

Defines GSM, including changes in arousal and orgasm.

Visit

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia

Labrie et al., Menopause 2016

Prasterone eased painful sex and dryness compared with placebo.

Visit

Treating where it hurts: vestibule estradiol for postmenopausal dyspareunia

Goetsch et al., Menopause 2023

Estradiol cream on the vestibule cut intercourse pain in a 50-person trial.

Visit

Vaginal estrogen application techniques for prevention of urinary tract infection (TAPER)

Obstetrics & Gynecology 2026

Cream around the urethra worked about as well as the applicator for repeat UTIs.

Visit

Genitourinary syndrome of lactation

Perelmuter et al., Sexual Medicine Reviews 2024

Proposes GSL; notes no treatment guidelines yet.

Visit

Systemic or vaginal hormone therapy after early breast cancer: a Danish cohort study

Cold et al., JNCI 2022

Small rise in recurrence only among aromatase inhibitor users.

Visit

17β-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream

Rioux et al., Menopause 2000

Equal relief; fewer people stopped the tablet than the cream.

Visit

Lichen sclerosus

NHS

A skin condition that causes itchy, white patches on the vulva and needs its own treatment.

Visit

Mineral oil lubricants cause rapid deterioration of latex condoms

Voeller et al., Contraception 1989

Sixty seconds of mineral oil exposure cut condom strength by about 90%.

Visit

Intravaginal practices and risk of bacterial vaginosis and candidiasis

Brown et al., Obstetrics & Gynecology 2013

Petroleum jelly linked with twice the risk of bacterial vaginosis; oils with yeast. Small US cohort (141 people).

Visit